Yoshiko Ohgari

Mechanisms involved in delta-aminolevulinic acid (ALA)-induced photosensitivity of tumor cells: relation of ferrochelatase and uptake of ALA to the accumulation of protoporphyrin.

H. Matsui, S. Taketani, Yoshiko Ohgari, 2005, Biochemical pharmacology.

Heme-binding to the nuclear receptor retinoid X receptor alpha (RXRalpha) leads to the inhibition of the transcriptional activity.

T. Osumi, S. Taketani, Yoshiko Ohgari, 2008, Gene.

The role of nitric oxide in delta-aminolevulinic acid (ALA)-induced photosensitivity of cancerous cells.

H. Matsui, S. Taketani, Yoshiko Ohgari, 2007, Biochemical and biophysical research communications.

Ferrochelatase consisting of wild-type and mutated subunits from patients with a dominant-inherited disease, erythropoietic protoporphyria, is an active but unstable dimer.

H. Kohno, S. Taketani, Yoshiko Ohgari, 2005, Human molecular genetics.

Quinolone compounds enhance delta-aminolevulinic acid-induced accumulation of protoporphyrin IX and photosensitivity of tumour cells.

Tuan Thanh Chau, Y. Adachi, S. Taketani, 2011, Journal of biochemistry.

Dual mitochondrial localization and different roles of the reversible reaction of mammalian ferrochelatase

A. Yamamoto, R. Masaki, S. Taketani, 2009, The FEBS journal.

Roles of Porphyrin and Iron Metabolisms in the δ‐Aminolevulinic Acid (ALA)‐induced Accumulation of Protoporphyrin and Photodamage of Tumor Cells

T. Kataoka, K. Furuyama, S. Taketani, 2011, Photochemistry and photobiology.

Heme synthase (ferrochelatase) catalyzes the removal of iron from heme and demetalation of metalloporphyrins.

Sakihito Kitajima, M. Numata, S. Taketani, 2007, Biochemistry.